2021年11月23日
;97 (21)
金博宝手机版官网首页
组织2-Hydroxyglutarate和弥漫性神经胶质瘤术前患者的癫痫
视图ORCID概要Makoto Ohno,Yoshiharu Hayashi,Aikawa总裁中西宏明,Hayashi村三,Yasuji Miyakita,正通高桥,裕子松下,Akihiko吉田,Kaishi Satomi,Koichi Ichimura,Akinobu石漠,Yoshitaka成田机场
第一次出版2021年10月5日,
DOI: https://doi.org/10.1212/WNL.0000000000012893
Makoto Ohno
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
Yoshiharu Hayashi
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
Aikawa总裁中西宏明
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
Hayashi村三
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
Yasuji Miyakita
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
正通高桥
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
裕子松下
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
Akihiko吉田
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
Kaishi Satomi
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
Koichi Ichimura
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
Akinobu石漠
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
Yoshitaka成田机场
神经外科神经肿瘤学学会举办和部门的路子、y Miyakita M.T.,Y. Matsushita, Y.N.) and Diagnostic Pathology (A.Y., K.S.), National Cancer Center Hospital; Divisions of Molecular Pharmacology (Y.H., A.H.) and Brain Tumor Translational Research (K.I.), National Cancer Center Research Institute; Division of Clinical Pharmacology and Translational Research, Exploratory Oncology Research and Clinical Trial Center (Y.H., H.A., M.H., A.H.), National Cancer Center; and Department of Medical Oncology and Translational Research (Y.H., A.H.), Graduate School of Medical Sciences, Kumamoto University, Tokyo,日本。
组织2-Hydroxyglutarate和弥漫性神经胶质瘤术前患者的癫痫
MakotoOhno,Yoshiharu哈亚希,总裁中西宏明Aikawa,三哈亚希,YasujiMiyakita,正通高桥,裕子松下,Akihiko吉田,KaishiSatomi,KoichiIchimura,Akinobu石漠,Yoshitaka成田机场
首页
2021年11月,
97年
(21)
e2114-e2123;
DOI:10.1212 / WNL.0000000000012893
做出评论
看到评论
这篇文章需要订阅查看全文。如果你有一个订阅你可以用下面的登录表单查看文章。这篇文章也可以购买。
寻求帮助,请联系:
河畔成员(800)879 - 1960或(612)928 - 6000(国际)
Non-AAN会员用户(800)638 - 3030或(301)223 - 2300选项3,选择1(国际)
报名
信息订阅神经病学和神经学:临床实践中可以找到首页在这里
购买
个人访问的文章可以通过这篇文章页面上加入购物车选项。获得1天(从您目前正在使用的计算机)是39.00美元。按次计费的内容仅供使用收款人和内容可能不会进一步分布式打印或电子手段。收款人可以查看、下载或打印文章为他/她的个人、学术研究和教学使用。分发副本(电子或其他方式)的文章是不允许的。